Khadilkar, V VKhadilkar, A VNandy, MMaskati, G B2006-03-062009-05-272006-03-062009-05-272006-03-06Khadilkar VV, Khadilkar AV, Nandy M, Maskati GB. Growth hormone in turner syndrome. Indian Pediatrics. 2006 Mar; 43(3): 236-40http://imsear.searo.who.int/handle/123456789/10186We assessed the effect of one year of therapy with recombinant Human Growth Hormone (rhGH) on growth velocity of 16 Indian girls with Turner Syndrome (TS) in a prospective, open trial. Patients received rhGH in a dose of 1 IU (0.3 mg)/kg/week. The mean pretreatment height was 117.1 cms (Z score minus 3.4), height velocity was 3.8 cm per year (Z score minus 2.4), and predicted height was 140 cm. At the end of therapy mean height was 123.9 (Z score minus 3.1), height velocity was 6.7 cm per year (Z score + 1.7), and the predicted height was 142.4 cm. The increment in height velocity with growth hormone therapy was statistically significant (P value = 0.001) and the mean increment in predicted height was 2.4 cm. Our study shows that girls with TS in India benefit from therapy with rhGH.engAdolescentChildFemaleGrowth --drug effectsHuman Growth Hormone --therapeutic useHumansProspective StudiesRecombinant ProteinsTurner Syndrome --drug therapyClinical Trial